Melatonin—its role in your life. Part 1: Biosynthesis, regulation, physiology and pharmacology

The recent TGA decision to down-schedule melatonin in modified release tablets containing 2mg or less of melatonin for the short-term treatment of primary insomnia, and approval for it to be advertised, means pharmacists are likely to receive more inquiries about it from their patients. In this first of two articles, pharmacist David Pache explains the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?